We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cephalon to Pay U.S. $1.2 Billion to Settle Pay-for-Delay Charges
Cephalon to Pay U.S. $1.2 Billion to Settle Pay-for-Delay Charges
Cephalon has agreed to pay the federal government $1.2 billion to settle antitrust allegations that it illegally blocked competition to Provigil by paying generics makers to hold off on their versions of the blockbuster narcolepsy drug.